Alnylam Pharmaceuticals
ALNY
#547
Rank
$43.76 B
Marketcap
$331.24
Share price
-5.89%
Change (1 day)
19.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company